SCHEMBL14976574

SCHEMBL14976574

Cc1c(NCC(=O)OC(C)(C)C)cccc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ PPARG P37231 1/20 0.44
▸ NR1H4 Q96RI1 1/20 0.44
▸ RAB9A P51151 6/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ AGTR1 P30556 1/20 0.42
▸ CYP2C9 P11712 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ AKR1C3 P42330 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19451380 0.89 KDM4E (0.42) ALDH1A1SMN1; SMN2PPARGNR1H4RAB9A
SCHEMBL5956241 0.87 KDM4E (0.56) ALDH1A1SMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL14976573 0.81 POLB (0.46) ALDH1A1KDM4EHSD17B10CYP2C9MEN1
SCHEMBL3248129 0.78 NPC1 (0.54) ALDH1A1SMN1; SMN2PPARGNR1H4RAB9A
SCHEMBL6437790 0.78 MAPT (0.47) ALDH1A1SMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL7860463 0.78 KDM4E (0.49) ALDH1A1RAB9ANPC1KDM4EAGTR1
SCHEMBL7434506 0.77 KDM4E (0.57) ALDH1A1SMN1; SMN2NPC1KDM4EHSD17B10
SCHEMBL8052745 0.77 AGTR1 (0.51) ALDH1A1SMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL27557341 0.77 CDC25B (0.40) RAB9ANPC1KDM4EAGTR1MEN1
SCHEMBL31177967 0.76 KDM4E (0.43) ALDH1A1SMN1; SMN2NPC1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096559-B2 4-carboxybenzylamino derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-08-04 — — US disclosed
US-20130137690-A1 4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME LLC 2013-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137690-A1 4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS BRDT, HDAC4, HDAC5 ALDH1A1 763/4885SMN1; SMN2 1302/4885PPARG 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback